K242706: Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K242706 (Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, cleared 2025-05-16 for Fujirebio Diagnostics,Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K242706 |
| Cleared Device Trade / Generic Name | Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio |
| FDA Applicant on Filing | Fujirebio Diagnostics,Inc. |
| FDA 3-Letter Product Classification | Product Code SET |
| FDA Substantial Equivalence Decision Date | 2025-05-16 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Fujirebio Diagnostics,Inc., compare peer devices under FDA Product Code SET, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.